Life-changing breakthroughs through clinical studies.
This study evaluates the tolerability, safety and activity of SRX246 in the treatment of
irritability in patients with Huntington's disease. Two-thirds of all participants will
receive SRX246, while the other third will receive a placebo.
A Pioneer like you can advance medicine for everyone
Become A Pioneer